Terravia (OTCMKTS: TVIAQ) is one of 47 public companies in the “Specialty Chemicals” industry, but how does it weigh in compared to its peers? We will compare Terravia to related businesses based on the strength of its risk, institutional ownership, valuation, analyst recommendations, earnings, profitability and dividends.

Risk and Volatility

Terravia has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500. Comparatively, Terravia’s peers have a beta of 1.32, suggesting that their average share price is 32% more volatile than the S&P 500.

Valuation & Earnings

This table compares Terravia and its peers gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Terravia $18.48 million -$101.55 million 0.00
Terravia Competitors $1.91 billion $115.75 million 228.49

Terravia’s peers have higher revenue and earnings than Terravia. Terravia is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Institutional and Insider Ownership

0.3% of Terravia shares are owned by institutional investors. Comparatively, 65.3% of shares of all “Specialty Chemicals” companies are owned by institutional investors. 10.1% of Terravia shares are owned by insiders. Comparatively, 7.4% of shares of all “Specialty Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.


This table compares Terravia and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Terravia -413.48% N/A -61.89%
Terravia Competitors -655.92% -4.30% 0.36%

Analyst Ratings

This is a breakdown of current ratings and target prices for Terravia and its peers, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Terravia 0 1 0 0 2.00
Terravia Competitors 171 1040 1311 24 2.47

Terravia currently has a consensus target price of $1.50, suggesting a potential upside of 33,233.33%. As a group, “Specialty Chemicals” companies have a potential downside of 0.30%. Given Terravia’s higher possible upside, research analysts plainly believe Terravia is more favorable than its peers.


Terravia peers beat Terravia on 8 of the 12 factors compared.

Terravia Company Profile

Solazyme, Inc. creates renewable oils and bioproducts. The Company’s technology uses microalgae in an industrial fermentation process to transform a range of plant-based sugars into triglyceride oils and other bioproducts. The Company offers Algenist, a skin and personal care product available at Sephora S.A. and its affiliates, QVC, Inc., SpaceNK Limited, select Nordstrom stores and ULTA Beauty. It offers intermediates/ingredients, such as Tailored oils, powdered oils, and other closely related products targeted at customers in the industrial products, food products and personal care products markets. The Company’s commercial focus is to sell oils, encapsulated oils and whole algal powdered products to companies that use them as intermediates and ingredients.

Receive News & Ratings for Terravia Holdings Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terravia Holdings and related companies with MarketBeat.com's FREE daily email newsletter.